Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,422,312
+$2,280,857 QoQ
Shares Held
73,209
-1.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#646
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $126,380,504 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,385 | $43,641,264 | |
| 2 | JNJ |
Johnson & Johnson
|
92,571 | $23,510,256 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
73,209 | $18,422,312 | |
| 4 | MRK |
Merck & Co., Inc.
|
123,237 | $15,835,954 | |
| 5 | AMGN |
Amgen Inc
|
19,733 | $7,145,713 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,562 | $4,492,903 | |
| 7 | NVS |
Novartis AG
|
17,467 | $2,737,428 | |
| 8 | PFE |
Pfizer Inc
|
110,237 | $2,654,506 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,422,312 | 73,209 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,141,455 | 74,217 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $16,791,728 | 73,490 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $16,557,425 | 71,510 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $13,519,075 | 72,832 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,955,079 | 66,605 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,591,015 | 65,228 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,257,781 | 62,071 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $10,062,392 | 58,666 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,573,454 | 58,064 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,534,042 | 55,069 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,873,498 | 52,821 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $6,868,804 | 50,982 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $8,356,247 | 52,433 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,276,209 | 51,211 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $8,512,785 | 55,581 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $8,646,461 | 53,337 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $7,551,122 | 55,769 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,440,792 | 41,168 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,683,458 | 41,579 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,410,506 | 40,755 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $1,228,903 | 11,469 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,314,318 | 37,839 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,733,392 | 38,026 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,003,181 | 39,417 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||